Deep Brain Stimulation for Spinocerebellar Ataxias

This trial tests a treatment called deep brain stimulation (DBS) to determine its safety and feasibility for people with certain types of spinocerebellar ataxia (SCA), a condition affecting balance and coordination. The main goal is to identify any side effects or issues from the treatment. Researchers also aim to assess whether DBS can alleviate symptoms and improve movement. This trial may suit adults diagnosed with moderate SCA type 1 or 3 who continue to experience symptoms despite regular treatment. As an unphased trial, it offers patients the chance to contribute to groundbreaking research that could lead to new treatment options.

The trial protocol does not specify if you need to stop taking your current medications, but you must have been on a stable treatment plan for at least 3 months before joining. You cannot participate if you are unable to stop blood-thinning medications for study procedures.

Research has shown that deep brain stimulation (DBS) is generally safe for patients with movement disorders, including some types of ataxia. In one study, patients did not experience major problems from the treatment. Another study examined a patient with a different type of ataxia and found a significant reduction in tremor severity, suggesting the treatment can be effective without causing significant harm.

However, some reports have mentioned complications, such as stimulation-induced ataxia, in a small number of cases, ranging from 5% to 40%. This indicates that while the treatment is mostly safe, there is a chance of experiencing some movement-related side effects. Despite these potential issues, researchers continue to study DBS because of its possible benefits for ataxia patients.

Unlike the standard of care for spinocerebellar ataxias, which often involves medication to manage symptoms, Deep Brain Stimulation (DBS) offers a unique approach by directly targeting brain activity. DBS involves surgically implanting electrodes into specific brain areas to regulate abnormal signals, which could potentially improve motor control and coordination. Researchers are excited about DBS because it provides a more direct and possibly more effective way to address the neurological basis of the condition, rather than just alleviating symptoms. This could lead to significant improvements in quality of life for patients who currently have limited treatment options.

Research has shown that deep brain stimulation (DBS) can improve symptoms in people with movement disorders, including certain types of ataxia. In this trial, participants will undergo DBS intervention, which involves surgical implantation of the DBS leads and a pulse generator. Previous studies demonstrated significant improvements in people with spinocerebellar ataxia, with benefits appearing as soon as six months after treatment. Specifically, in cases of SCA12, DBS reduced tremor severity by 76%. Additionally, combining DBS with exercise improved muscle function and mobility in ataxia models. These findings suggest that DBS could be a promising option for managing symptoms of spinocerebellar ataxia.⁴⁶⁷⁸⁹